Skip to main content
Top
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Decubitus positioning for stereotactic core biopsy

Authors: CE Ingram, S Nutton, S Dunhill

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

Digital stereotaxis has made biopsy of microcalcifications more effective. Results with the upright units mainly available in the UK have been shown to be comparable with those obtained on dedicated prone biopsy tables. Some women suffer vasovagal attacks while in the sitting position and this complication led us to develop the decubitus method, in which the woman lies on her side on a trolley. The breast to be biopsied is positioned uppermost and entered from a lateromedial approach. The woman can be rolled towards the prone position until the sternum touches the edge of the grid. This position has been found to be stable and comfortable for the patient. It allows easy access to the breast and allows posterior lesions to be reached. An alternative mediolateral approach is possible with the affected breast inferior and the upper breast taped back, with the patient in an anterior oblique position. These methods have proved valuable for "fainters" and for disabled women, including those with severe shoulder and neck arthritis. Because of the increased operator and patient comfort, we are tending to adopt this method for all stereotactic core biopsies. …
Metadata
Title
Decubitus positioning for stereotactic core biopsy
Authors
CE Ingram
S Nutton
S Dunhill
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr244

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine